These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 34743203)

  • 1. Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-β-catenin-STAT3 signaling.
    Hu S; Ren S; Cai Y; Liu J; Han Y; Zhao Y; Yang J; Zhou X; Wang X
    Cell Death Differ; 2022 Mar; 29(3):642-656. PubMed ID: 34743203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway.
    Wang Z; Ran X; Qian S; Hou H; Dong M; Wu S; Ding M; Zhang Y; Zhang X; Zhang M; Chen Q
    Arch Biochem Biophys; 2021 Oct; 710():108998. PubMed ID: 34280359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA FIRRE is activated by MYC and promotes the development of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway.
    Shi X; Cui Z; Liu X; Wu S; Wu Y; Fang F; Zhao H
    Biochem Biophys Res Commun; 2019 Mar; 510(4):594-600. PubMed ID: 30739786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein nucleolar 3 promotes Non-Hodgkin lymphoma progression by activating the Wnt/β-catenin signaling pathway.
    Dai R; Wu M; Zhang Y; Zhu Z; Shi J
    Exp Cell Res; 2021 Dec; 409(2):112911. PubMed ID: 34762898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXM1-induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway.
    Meng H; Zhao B; Wang Y
    Exp Mol Pathol; 2020 Aug; 115():104451. PubMed ID: 32417392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis.
    Zhao CX; Yan ZX; Wen JJ; Fu D; Xu PP; Wang L; Cheng S; Hu JD; Zhao WL
    Mol Cancer; 2021 Dec; 20(1):153. PubMed ID: 34852843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC.
    Zhao CC; Jiao Y; Zhang YY; Ning J; Zhang YR; Xu J; Wei W; Kang-Sheng G
    Cell Death Dis; 2019 Mar; 10(4):252. PubMed ID: 30874550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiles analysis identifies a novel two-gene signature to predict overall survival in diffuse large B-cell lymphoma.
    Sun C; Cheng X; Wang C; Wang X; Xia B; Zhang Y
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30393234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-MYC-activated lncRNA SNHG20 accelerates the proliferation of diffuse large B cell lymphoma via USP14-mediated deubiquitination of β-catenin.
    Wang C; Fu W; Zhang Y; Hu X; Xu Q; Tong X
    Biol Direct; 2024 Jun; 19(1):47. PubMed ID: 38886753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FKBP3 aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of Wnt/β-catenin signalling.
    Xing X; Liu M; Wang X; Guo Q; Wang H; Wang W
    J Cell Mol Med; 2024 Jan; 28(1):e18041. PubMed ID: 37987202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metadherin contributes to the pathogenesis of diffuse large B-cell lymphoma.
    Ge X; Lv X; Feng L; Liu X; Gao J; Chen N; Wang X
    PLoS One; 2012; 7(6):e39449. PubMed ID: 22768080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression.
    Liu L; Ning Y; Yi J; Yuan J; Fang W; Lin Z; Zeng Z
    Biomed Pharmacother; 2020 May; 125():109865. PubMed ID: 32058212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLAGL2 Promotes the Proliferation and Migration of Diffuse Large B-cell Lymphoma Cells via Wnt/β-catenin Pathway.
    Jin W; Wang X
    Ann Clin Lab Sci; 2022 May; 52(3):359-366. PubMed ID: 35777795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis.
    Ye G; Yang Q; Lei X; Zhu X; Li F; He J; Chen H; Ling R; Zhang H; Lin T; Liang Z; Liang Y; Huang H; Guo W; Deng H; Liu H; Hu Y; Yu J; Li G
    Theranostics; 2020; 10(17):7545-7560. PubMed ID: 32685004
    [No Abstract]   [Full Text] [Related]  

  • 15. Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas.
    Bognar MK; Vincendeau M; Erdmann T; Seeholzer T; Grau M; Linnemann JR; Ruland J; Scheel CH; Lenz P; Ott G; Lenz G; Hauck SM; Krappmann D
    Oncogene; 2016 Aug; 35(32):4269-81. PubMed ID: 26776161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/β-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9).
    Zhang H; Liu S; Tang L; Ge J; Lu X
    Bioengineered; 2021 Dec; 12(1):162-171. PubMed ID: 33356805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling.
    Lin Y; Chen X; Lin L; Xu B; Zhu X; Lin X
    Cell Mol Biol Lett; 2024 May; 29(1):63. PubMed ID: 38698330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma.
    Walker MP; Stopford CM; Cederlund M; Fang F; Jahn C; Rabinowitz AD; Goldfarb D; Graham DM; Yan F; Deal AM; Fedoriw Y; Richards KL; Davis IJ; Weidinger G; Damania B; Major MB
    Sci Signal; 2015 Feb; 8(362):ra12. PubMed ID: 25650440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA SNHG16 contributes to the development of bladder cancer via regulating miR-98/STAT3/Wnt/β-catenin pathway axis.
    Feng F; Chen A; Huang J; Xia Q; Chen Y; Jin X
    J Cell Biochem; 2018 Nov; 119(11):9408-9418. PubMed ID: 30132983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-specific protease 15 contributes to gastric cancer progression by regulating the Wnt/β-catenin signaling pathway.
    Zhong M; Zhou L; Fang Z; Yao YY; Zou JP; Xiong JP; Xiang XJ; Deng J
    World J Gastroenterol; 2021 Jul; 27(26):4221-4235. PubMed ID: 34326621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.